ARDX vs REGN: Which Stock is Better?

Side-by-side comparison of Ardelyx Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

ARDX

Ardelyx Inc

$6.04

REGN

Regeneron Pharmaceuticals Inc

$614.78

Key Metrics Comparison

MetricARDXREGNWinner
Market Cap$1.52B$65.81BREGN
P/E RatioN/A15.34REGN
EPS (TTM)$N/A$40.93REGN
Revenue Growth0.3%0.2%ARDX
Gross Margin74.6%43.9%ARDX

Analyze ARDX

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ARDX or REGN a better investment?

Comparing ARDX and REGN: Ardelyx Inc has a market cap of $1.52B while Regeneron Pharmaceuticals Inc has $65.81B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ARDX and REGN?

ARDX (Ardelyx Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ARDX or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ARDX or REGN?

ARDX has higher revenue growth at 0.3% vs 0.2% for REGN.

Which company is more profitable: ARDX or REGN?

Ardelyx Inc (ARDX) has higher gross margins at 74.6% compared to 43.9% for REGN.

Which is the larger company: ARDX or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $65.81B compared to $1.52B for ARDX.

Should I buy ARDX or REGN in 2026?

Both ARDX and REGN have investment merit. ARDX trades at $6.04 while REGN trades at $614.78. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ARDX and REGN stock?

Key differences: Market Cap ($1.52B vs $65.81B), P/E Ratio (N/A vs 15.3x), Revenue Growth (0.3% vs 0.2%), Gross Margin (74.6% vs 43.9%).

Popular Stock Comparisons